PRELUDE CAPITAL MANAGEMENT, LLC - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 146 filers reported holding THERAPEUTICSMD INC in Q1 2020. The put-call ratio across all filers is 1.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q4 2021$4,000
-71.4%
11,000
+6.8%
0.00%
Q1 2021$14,000
+1300.0%
10,300
+1371.4%
0.00%
Q3 2020$1,0000.0%7000.0%0.00%
Q2 2020$1,000
-66.7%
700
-50.7%
0.00%
Q4 2019$3,000
-50.0%
1,421
-9.9%
0.00%
Q3 2019$6,000
+50.0%
1,577
-2.7%
0.00%
Q2 2019$4,000
+300.0%
1,620
+639.7%
0.00%
Q4 2018$1,000
-96.4%
219
-91.9%
0.00%
-100.0%
Q4 2015$28,000
-92.3%
2,700
-96.1%
0.00%
-93.3%
Q4 2013$365,00070,0000.06%
Other shareholders
THERAPEUTICSMD INC shareholders Q1 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,460,225$24,914,0004.95%
Newtyn Management, LLC 1,800,000$12,960,0001.95%
1492 Capital Management LLC 222,485$1,602,0001.25%
SANDERS MORRIS HARRIS LLC 967,200$6,964,0001.18%
MORGENS WATERFALL VINTIADIS & CO INC 180,000$1,296,0001.15%
SPHERA FUNDS MANAGEMENT LTD. 580,000$4,176,0000.82%
Rock Springs Capital Management LP 1,600,000$11,520,0000.66%
STONERIDGE INVESTMENT PARTNERS LLC 467,425$3,365,0000.45%
Capital Impact Advisors, LLC 157,411$1,133,0000.45%
GILDER GAGNON HOWE & CO LLC 3,059,690$22,030,0000.37%
View complete list of THERAPEUTICSMD INC shareholders